Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Sensitivity to Vγ9Vδ2TCR T cells is imprinted after single mutations during early oncogenesis
Astrid Cleven, Angelo D. Meringa, Péter Brázda, Domenico Fasci, Thijs Koorman, Tineke Aarts, Inez Johanna, Dennis X. Beringer, Patricia Hernández-López, Sabine Heijhuurs, Tomohiro Mizutani, Sangho Lim, Maarten A. Huismans, Jochem H. Bernink, Donel González-Díaz, Wei Wu, Ester San José, Joerg Schipper, Nikos Tsakirakis, Lauren Hoorens Van Heyningen, Amanda Nouwens, Lucrezia C D E Gatti, Trudy Straetemans, Hugo J.G. Snippert, Jeanine Roodhart, Patrick W.B. Derksen, Jarno Drost, Maarten Altelaar, Albert J. R. Heck, Hans Clevers, Jürgen Kuball, Zsolt Sebestyén (2024). Sensitivity to Vγ9Vδ2TCR T cells is imprinted after single mutations during early oncogenesis. , DOI: https://doi.org/10.1101/2024.11.19.624272.
Preprint23 days agoDual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cells
Patricia Hernández-López, Eline van Diest, Péter Brázda, Sabine Heijhuurs, Angelo D. Meringa, Lauren Hoorens Van Heyningen, Caterina Riillo, Caroline Schwenzel, Marina Zintchenko, Inez Johanna, Mara J.T. Nicolasen, Astrid Cleven, Thomas A. Kluiver, Rosemary Millen, Jiali Zheng, Froso Karaiskaki, Trudy Straetemans, Hans Clevers, Remco de Bree, Hendrik G. Stunnenberg, Weng Chuan Peng, Jeanine Roodhart, Susana Minguet, Zsolt Sebestyén, Dennis X. Beringer, Jürgen Kuball (2023). Dual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cells. , 25(1), DOI: https://doi.org/10.1038/s41590-023-01665-0.
Article23 days agoUncovering the mode of action of engineered T cells in patient cancer organoids
Johanna F. Dekkers, María Alieva, Astrid Cleven, Farid Keramati, Amber K. L. Wezenaar, Esmée J. van Vliet, Jens Puschhof, Péter Brázda, Inez Johanna, Angelo D Meringa, Heggert G. Rebel, Maj‐Britt Buchholz, Mario Barrera Román, Amber L. Zeeman, Sam de Blank, Domenico Fasci, Maarten H. Geurts, Annelisa M. Cornel, Else Driehuis, Rosemary Millen, Trudy Straetemans, Mara J.T. Nicolasen, Tineke Aarts-Riemens, Hendrikus C. R. Ariese, Hannah R Johnson, Ravian L van Ineveld, Froso Karaiskaki, Oded Kopper, Yotam E. Bar‐Ephraïm, Kai Kretzschmar, Alexander M.M. Eggermont, Stefan Nierkens, Ellen J. Wehrens, Henk G. Stunnenberg, Hans Clevers, Jürgen Kuball, Zsolt Sebestyén, Anne C. Rios, Johanna F. Dekkers, María Alieva, Astrid Cleven, Farid Keramati, Amber K. L. Wezenaar, Esmée J. van Vliet, Jens Puschhof, Péter Brázda, Inez Johanna, Angelo D Meringa, Heggert G. Rebel, Maj‐Britt Buchholz, Mario Barrera Román, Amber L. Zeeman, Sam de Blank, Domenico Fasci, Maarten H. Geurts, Annelisa M. Cornel, Else Driehuis, Rosemary Millen, Trudy Straetemans, Mara J.T. Nicolasen, Tineke Aarts-Riemens, Hendrikus C. R. Ariese, Hannah R Johnson, Ravian L van Ineveld, Froso Karaiskaki, Oded Kopper, Yotam E. Bar‐Ephraïm, Kai Kretzschmar, Alexander M.M. Eggermont, Stefan Nierkens, Ellen J. Wehrens, Henk G. Stunnenberg, Hans Clevers, Jürgen Kuball, Zsolt Sebestyén, Anne C. Rios (2022). Uncovering the mode of action of engineered T cells in patient cancer organoids. , 41(1), DOI: https://doi.org/10.1038/s41587-022-01397-w.
Article23 days agoUncovering the mode of action of engineered T cells in patient cancer organoids
Johanna F. Dekkers, María Alieva, Astrid Cleven, Farid Keramati, Amber K. L. Wezenaar, Esmée J. van Vliet, Jens Puschhof, Péter Brázda, Inez Johanna, Angelo D Meringa, Heggert G. Rebel, Maj‐Britt Buchholz, Mario Barrera Román, Amber L. Zeeman, Sam de Blank, Domenico Fasci, Maarten H. Geurts, Annelisa M. Cornel, Else Driehuis, Rosemary Millen, Trudy Straetemans, Mara J.T. Nicolasen, Tineke Aarts-Riemens, Hendrikus C. R. Ariese, Hannah R Johnson, Ravian L van Ineveld, Froso Karaiskaki, Oded Kopper, Yotam E. Bar‐Ephraïm, Kai Kretzschmar, Alexander M.M. Eggermont, Stefan Nierkens, Ellen J. Wehrens, Henk G. Stunnenberg, Hans Clevers, Jürgen Kuball, Zsolt Sebestyén, Anne C. Rios, Johanna F. Dekkers, María Alieva, Astrid Cleven, Farid Keramati, Amber K. L. Wezenaar, Esmée J. van Vliet, Jens Puschhof, Péter Brázda, Inez Johanna, Angelo D Meringa, Heggert G. Rebel, Maj‐Britt Buchholz, Mario Barrera Román, Amber L. Zeeman, Sam de Blank, Domenico Fasci, Maarten H. Geurts, Annelisa M. Cornel, Else Driehuis, Rosemary Millen, Trudy Straetemans, Mara J.T. Nicolasen, Tineke Aarts-Riemens, Hendrikus C. R. Ariese, Hannah R Johnson, Ravian L van Ineveld, Froso Karaiskaki, Oded Kopper, Yotam E. Bar‐Ephraïm, Kai Kretzschmar, Alexander M.M. Eggermont, Stefan Nierkens, Ellen J. Wehrens, Henk G. Stunnenberg, Hans Clevers, Jürgen Kuball, Zsolt Sebestyén, Anne C. Rios (2022). Uncovering the mode of action of engineered T cells in patient cancer organoids. , 41(1), DOI: https://doi.org/10.1038/s41587-022-01397-w.
Article23 days agoBehavioral-transcriptomic landscape of engineered T cells targeting human cancer organoids
Johanna F. Dekkers, María Alieva, Astrid Cleven, Farid Keramati, Péter Brázda, Heggert Rebel, Amber K. L. Wezenaar, Jens Puschhof, Maj‐Britt Buchholz, Mario Barrera Román, Inez Johanna, Angelo D. Meringa, Domenico Fasci, Maarten H. Geurts, Hendrikus CR Ariese, Esmée J. van Vliet, Ravian L. van Ineveld, Effrosyni Karaiskaki, Oded Kopper, Yotam E. Bar‐Ephraïm, Kai Kretzschmar, Alexander M.M. Eggermont, Ellen J. Wehrens, Henk G. Stunnenberg, Hans Clevers, Jürgen Kuball, Zsolt Sebestyén, Anne C. Rios (2021). Behavioral-transcriptomic landscape of engineered T cells targeting human cancer organoids. , DOI: https://doi.org/10.1101/2021.05.05.442764.
Preprint15 days ago